Loading…
Loading…
| # | Company | Amount | Status |
|---|---|---|---|
| 1 | ₹1.1 CrAdmitted-Finance | ₹1.1 Cr | Admitted-Finance |
| 2 | ₹31.9 CrAdmitted-Finance | ₹31.9 Cr | Admitted-Finance |
| Sl No | Description | Qty | Unit | Shreeji Imaging and Diagnostic Centre Private Limited | Dhanratna Enterprises |
|---|---|---|---|---|---|
| 1.00 | Technical consultancy for development of 30 MeV cyclotron based GMP compliant radio-pharma facility for production of radiopharmaceuticals used in PET /SPECT/ radiotherapy application and research application
(Details Specifications as per Technical Bid) | 1 | Nos. | 27,00,00,000 ₹31,86,00,000 | 90,00,000 ₹1,06,20,000 Lowest |
Tender Value
Refer Docs
Closing Date
31 Jul 2025, 11:00 amClosed
Director, NISER
NISER, Bhubaneswar
Technical Consultancy for development of 30 MeV Cyclotron based GMP compliant Radio-pharma facility for production of radiopharmaceuticals used in PET/SPECT/Radiotherapy application and research application
2025_NISER_864487_1
C-000971-30 MeV Medical Cyclotron Facility at NISER-24-25
Limited
Consultancy
Buy
1825 days
NISER, Bhubaneswar
Please refer Tender documents.
2 documents required · 2 mandatory
₹0
Exempted
25 Aug 2025
18 Jun 2025
1 Aug 2025
18 Jun 2025
31 Jul 2025
19 Jun 2025
Technical consultancy for development of 30 MeV cyclotron based GMP compliant radio-pharma facility for production of radiopharmaceuticals used in PET /SPECT/ radiotherapy application and research application (Details Specifications as per Technical Bid)
stage.html
html • 0.03 MB
tech_eval.pdf
boq_comp_chart.xlsx
xlsx
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
details.html
html • 0.03 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .